approval · primary record
NOREPINEPHRINE BITARTRATE
FDA · NDA · 2026-02-06
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2026-02-06 |
| Brand | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE |
| Sponsor | BAXTER HLTHCARE CORP |
| Route | INTRAVENOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:34:13.952Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:NOREPINEPHRINE BITARTRATE:2026-02-06
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.